Navigation Links
Nasulin Interim Results to Be Presented at American Diabetes,Association Scientific Sessions

EXETER, N.H.--(BUSINESS WIRE)--Apr 10, 2007 - Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that its abstract entitled "Interim Results of a Randomized, Single-Dose, 4-Way Crossover, Pharmacokinetic Study of Intranasal Insulin Spray (Nasulin(TM)), Injectable Regular Insulin (Humulin R(R)), Injectable Fast-Acting Insulin (Humalog(R)), and Saline Nasal Spray in Patients with Type I Diabetes Mellitus," has been selected for oral presentation at the American Diabetes Association 67th Scientific Sessions in Chicago. Dr. Sherwyn L. Schwartz, M.D., of dgd Research, Inc., will make the presentation as part of the first session on Friday, June 22, 2007.

Another Bentley sponsored study has also been accepted for a poster presentation in the category Clinical Therapeutics/New Technology - Insulin Delivery Systems. The poster abstract, "Intranasulin Insulin Spray (Nasulin(TM)) in Healthy Subjects: Choice of Nostril," will be displayed Saturday through Monday, June 23-25, 2007, in the General Poster Session in the Exhibit Hall.

Founded in 1979 by Dr. Schwartz, the Diabetes & Glandular Disease Clinic is the largest private endocrine clinic in the United States with over 70,000 active patients, eight board certified endocrinologists, seven NPs/PAs and an ADA recognized diabetes education program. The research arm, dgd Research Associates, Inc., has a staff of over 250 employees and has conducted over 1,500 Phase I through III clinical trials, primarily in targeted endocrine populations. Currently work is underway on construction of a new 80,000sq. ft. Phase I unit. For more information visit www.dgdclinic.com and www.dgdresearch.com.

Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products. Bentley's proprietary drug delivery technologies enhance the absorption of pha
'"/>




Page: 1 2 3

Related medicine technology :

1. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
8. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
9. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
10. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... NEW YORK , Jan. 19 As part ... Parkinson,s disease, The Michael J. Fox Foundation for Parkinson,s Research ... to six biotech and pharmaceutical companies under its industry-exclusive ... projects pushing forward investigations of promising neuroprotective therapeutic targets for ...
... , THE WOODLANDS, ... Foundation announced today that it is changing its name to ... essence of hope that the organization aspires to provide to cancer ... enhance cancer care in local communities by removing barriers to prevention, ...
Cached Medicine Technology:Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams' Pre-Clinical Development of Neuroprotective Parkinson's Therapies 2Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams' Pre-Clinical Development of Neuroprotective Parkinson's Therapies 3US Oncology Foundation Becomes Life Beyond Cancer Foundation 2US Oncology Foundation Becomes Life Beyond Cancer Foundation 3
(Date:7/9/2014)... -- Researchers from The Miriam Hospital have ... (COPD) who are also depressed have difficulty sticking ... be particularly true for women, and screening and ... part of treatment. The study and its findings ... . , Chronic obstructive pulmonary disease is ...
(Date:7/9/2014)... and extinctions around the world have been linked ... new research from the National Institute for Mathematical ... ranavirus, may also contribute. , In a ... which causes severe hemorrhage of internal organs in ... wood frogs if they are exposed to the ...
(Date:7/9/2014)... study conducted by researchers at Tufts University School of ... intellectual and developmental disabilities, the likelihood of having cavities ... increased. The findings, published in the July/August issue of ... interventions designed to address the oral health of individuals ... dental records of 107 patients at one of the ...
(Date:7/9/2014)... The occurrence of allergic diseases has risen dramatically in ... are less exposed to microorganisms and have fewer infections ... system. , A study by researchers at Sahlgrenska Academy, ... three to examine maturation of the immune system in ... in rural areas of the Vstra Gtaland Region, half ...
(Date:7/8/2014)... Plymouth, UK, and Sydney, Australia, have today (Wednesday 9th ... - a free-to-use app to support the assessment of ... of its kind; an iPad-based tool that supports the ... whole process, meaning more members of the clinical team ... Designed by clinicians for clinicians, ACEmobile also collects secure ...
Breaking Medicine News(10 mins):Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Adults with special needs see gains, challenges with long term oral care 2Health News:Adults with special needs see gains, challenges with long term oral care 3Health News:New app widens opportunities for dementia assessments 2Health News:New app widens opportunities for dementia assessments 3
... How people walk, jump and run and how their knees ... predicting years or even decades in advance whether they will ... of all Americans by the time they reach the age ... gait, leap, stride or scan and tell you definitively whether ...
... News) -- People whose parents had a drinking problem are ... stress, a new study says. Swedish researchers divided 58 ... a family history of alcohol abuse. Both groups were placed ... in public) and then allowed to drink. People who ...
... up just got more complicated. Thomas Jefferson University ... receptor for a major insect molting hormone doesn,t activate and ... genes, and it is out-competed by a heme-binding receptor to ... in the fruit fly. For the last 20 years, ...
... U.S. Food and Drug Administration and the National Institutes ... of tobacco users to monitor and assess the behavioral ... The initiative, called the Tobacco Control Act National Longitudinal ... collaboration on tobacco regulatory research since Congress granted FDA ...
... of open angle glaucoma important so that treatment can be ... prevent or avoid further vision loss. Writing in a forthcoming ... Informatics , researchers in the US have analyzed and ranked ... patients can be screened at an earlier stage if they ...
... News) -- ,Anemia increases the risk of death and complications ... heart operations, a new study says. It was known ... but anemia,s impact on non-cardiac surgical outcomes wasn,t clear. People ... For the new study, researchers analyzed data from more than ...
Cached Medicine News:Health News:$6.3 million center at UCSF and UC Davis seeks ways to diagnose and prevent osteoarthritis 2Health News:$6.3 million center at UCSF and UC Davis seeks ways to diagnose and prevent osteoarthritis 3Health News:Nuclear receptors battle it out during metamorphosis in new fruit fly model 2Health News:FDA and NIH announce joint study on tobacco use and risk perceptions 2Health News:Detecting glaucoma before it blinds 2Health News:Anemia Could Add to Surgical Risks 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: